• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺细胞病理学报告的术语和命名方案:概述

Terminology and nomenclature schemes for reporting thyroid cytopathology: An overview.

作者信息

Collins Jennifer, Rossi Esther Diana, Chandra Ashish, Ali Syed Z

机构信息

Department of Pathology, University of Maryland Medical Center, Baltimore, Maryland.

Division of Anatomic Pathology and Histology, Policlinico Agostino Gemelli, Univerista Cattolica del Sacro Cuore, Rome, Italy.

出版信息

Semin Diagn Pathol. 2015 Jul;32(4):258-63. doi: 10.1053/j.semdp.2014.12.007. Epub 2014 Dec 19.

DOI:10.1053/j.semdp.2014.12.007
PMID:25680862
Abstract

The clinical management of thyroid nodules begins with a cytologic diagnosis. Current multidisciplinary approaches to thyroid nodule management rely on clear and concise diagnoses that can be reliably and reproducibly interpreted across institutions. Ultimately, this clinical necessity has led to multidisciplinary bodies throughout the world to develop standardized reporting formats which have themselves evolved over time. Herein we review the three major international nomenclatures for reporting thyroid cytopathology, including, the British Thyroid Association and Royal College of Pathologists (Thy), the Italian Consensus (TIR) and the Bethesda System for Reporting Thyroid Cytopathology. Alignment of these three diagnostic terminologies and the emergence of a single internationally agreed upon one has the potential to lead to more succinct, evidence-driven clinical management algorithms.

摘要

甲状腺结节的临床管理始于细胞诊断。目前甲状腺结节管理的多学科方法依赖于清晰简洁的诊断,这些诊断能够在不同机构间得到可靠且可重复的解读。最终,这种临床需求促使全球各地的多学科机构制定标准化报告格式,这些格式也随着时间不断演变。在此,我们回顾三种主要的甲状腺细胞病理学报告国际命名法,包括英国甲状腺协会和皇家病理学家学院(Thy)、意大利共识(TIR)以及甲状腺细胞病理学报告贝塞斯达系统。这三种诊断术语的统一以及达成单一国际公认的术语,有可能带来更简洁、基于证据的临床管理算法。

相似文献

1
Terminology and nomenclature schemes for reporting thyroid cytopathology: An overview.甲状腺细胞病理学报告的术语和命名方案:概述
Semin Diagn Pathol. 2015 Jul;32(4):258-63. doi: 10.1053/j.semdp.2014.12.007. Epub 2014 Dec 19.
2
Analysis of the bethesda system for reporting thyroid cytopathology and similar precursor thyroid cytopathology reporting schemes.甲状腺细胞病理学报告贝塞斯达系统分析及类似的甲状腺前体细胞病理学报告方案。
Adv Anat Pathol. 2012 Sep;19(5):313-9. doi: 10.1097/PAP.0b013e3182666398.
3
Thyroid FNA terminology: The case for a single unified international system for thyroid FNA reporting.甲状腺细针穿刺术术语:建立甲状腺细针穿刺术报告的单一统一国际系统的理由。
Cytopathology. 2021 Nov;32(6):714-717. doi: 10.1111/cyt.13017. Epub 2021 Jun 15.
4
The UK Royal College of Pathologists thyroid fine-needle aspiration diagnostic classification is a robust tool for the clinical management of abnormal thyroid nodules.英国皇家病理学家学会甲状腺细针穿刺诊断分类是用于甲状腺异常结节临床管理的可靠工具。
Acta Cytol. 2011;55(6):499-506. doi: 10.1159/000333234. Epub 2011 Dec 9.
5
Pitfalls in the Cytological Assessment of Thyroid Nodules.甲状腺结节细胞学评估中的陷阱
Turk Patoloji Derg. 2015;31 Suppl 1:18-33. doi: 10.5146/tjpath.2015.01312.
6
Are we ready to bridge classification systems? A comprehensive review of different reporting systems in thyroid cytology.我们是否准备好弥合分类系统之间的差距了?甲状腺细胞学中不同报告系统的全面综述。
Cytopathology. 2024 Nov;35(6):674-681. doi: 10.1111/cyt.13411. Epub 2024 Jul 26.
7
The Bethesda terminology for reporting thyroid cytopathology: from theory to practice in Europe.用于报告甲状腺细胞病理学的贝塞斯达术语:欧洲的从理论到实践
Acta Cytol. 2011;55(6):507-11. doi: 10.1159/000334687. Epub 2011 Dec 9.
8
Thyroid cytopathology: Bethesda and beyond.甲状腺细胞病理学:贝塞斯达及其他。
Acta Cytol. 2011;55(1):4-12. doi: 10.1159/000322365. Epub 2010 Nov 26.
9
The impact of implementation of the Bethesda System for Reporting Thyroid Cytopathology on the quality of reporting, "risk" of malignancy, surgical rate, and rate of frozen sections requested for thyroid lesions.甲状腺细胞病理学报告贝塞斯达系统实施对报告质量、“恶性风险”、手术率和甲状腺病变冷冻切片请求率的影响。
Cancer Cytopathol. 2011 Oct 25;119(5):315-21. doi: 10.1002/cncy.20174. Epub 2011 Jul 12.
10
Malignancy risk for fine-needle aspiration of thyroid lesions according to the Bethesda System for Reporting Thyroid Cytopathology.根据甲状腺细胞病理学报告的 Bethesda 系统,对甲状腺病变进行细针穿刺抽吸的恶性风险。
Am J Clin Pathol. 2010 Sep;134(3):450-6. doi: 10.1309/AJCP5N4MTHPAFXFB.

引用本文的文献

1
Prediction model based on MRI morphological features for distinguishing benign and malignant thyroid nodules.基于 MRI 形态学特征的甲状腺良恶性结节鉴别预测模型。
BMC Cancer. 2024 Feb 23;24(1):256. doi: 10.1186/s12885-024-11995-3.
2
A Comparative Study of ARHI Imprinted Gene Detection and Fine-Needle Aspiration Cytology in the Differential Diagnosis of Benign and Malignant Thyroid Nodules.ARHI印记基因检测与细针穿刺细胞学检查在甲状腺良恶性结节鉴别诊断中的对比研究
Genet Test Mol Biomarkers. 2019 Sep;23(9):681-687. doi: 10.1089/gtmb.2019.0028. Epub 2019 Aug 14.
3
A combination of immunohistochemistry and molecular approaches improves highly sensitive detection of BRAF mutations in papillary thyroid cancer.
免疫组织化学和分子方法相结合可提高甲状腺乳头状癌中BRAF突变的高灵敏度检测。
Endocrine. 2016 Sep;53(3):672-80. doi: 10.1007/s12020-015-0720-9. Epub 2015 Aug 22.